| PD | Parkinson’s disease |
| SNpc | substantia nigra pars compacta |
| SNpr | substantia nigra pars reticulata |
| VTA | ventral tegmental area |
| V1 | visual cortex |
| M1 | motor cortex |
| PFC | prefrontal cortex |
| DLStr | dorsolateral striatum |
| VMStr | ventromedial striatum |
| Amy | amygdala |
| Thal | Thalamus |
| NR | nucleus ruber |
| DHip | dorsal hippocampus |
| VHip | ventral hippocampus |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 6-OHDA | 6-hydroxydopamine |
| VTA | ventral tegmental area |
| DMSO | dimethyl sulfoxide |
| mNSS | modified neurological severity scores |
| PBS | phosphate-buffered saline |
| LPO | lipid peroxidation |
| CL | Chemiluminescence |
| DA | Dopamine |
| 5-HT | Serotonin |
| NA | Noradrenaline |
| DOPAC | 3,4-dihydroxyphenylacetic acid |
| 3-MT | 3-methoxytyramine |
| HVA | homovanillic acid |
| 5-HIAA | 5-hydroxyindoleacetic acid |
| HPLC-ED | high-performance liquid chromatography with electrochemical detection |
| TH | tyrosine hydroxylase |
| DAPI | 4′,6-diamidino-2-phenylindole |
| NADH | nicotinamide adenine dinucleotide |